Exploratory evaluation of early 68Ga-FAPI-46 PET/CT volume-based parameters in systemic sclerosis-associated interstitial lung disease
- Open Access
- 02-02-2026
- Positron Emission Tomography
- Original Article
- Authors
- Sarah Beishan Tai
- Wei Ming Chua
- Cherie Wei Qi Ng
- Maria Noviani
- Wei Ping Tham
- Seyed Ehsan Saffari
- Winnie Wing Chuen Lam
- David Chee Eng Ng
- Adrian Shoen Choon Seng Low
- Wanying Xie
- Andrea Hsiu Ling Low
Abstract
Purpose
Systemic sclerosis-associated interstitial lung disease (SSc-ILD) is a severe complication of SSc, characterised by progressive fibrosis and inflammation. Current diagnostic tools do not accurately differentiate progressors from non-progressors, limiting timely intervention. 68Ga-FAPI-46 is a positron emission tomography (PET) tracer targeting fibroblast activation protein alpha (FAP), a marker of activated fibroblasts, with high affinity and retention. Optimal imaging timepoints and PET parameters for 68Ga-FAPI-46 PET/CT imaging in fibroinflammatory disorders remain undefined. This exploratory study investigated early versus late 68Ga-FAPI-46 PET parameters in evaluating SSc-ILD.
Methods
Early (10 min) and late (60 min) 68Ga-FAPI-46 PET parameters were compared between progressive (n = 8) and non-progressive SSc-ILD (n = 14), defined by INBUILD trial criteria. PET parameters were correlated with pulmonary function test (PFT) and HRCT parameters. Optimal thresholds for identified PET parameters were determined by closest-to-(0,1) criterion.
Results
Early total lesion FAPI uptake (median TL-FAPI10min 1245 vs. 714, p = 0.020) and affected lung volume (median AV10min 514 ml vs. 368 ml, p = 0.042) were significantly higher in progressors than non-progressors. Early PET parameters showed stronger, more consistent correlations with PFT and quantitative HRCT parameters than late PET parameters. Volume-based compared to intensity-based PET parameters more consistently correlated with PFT and quantitative HRCT parameters. TL-FAPI10min threshold of 928 had the best diagnostic performance (AUC 0.80).
Conclusion
This exploratory study showed that 68Ga-FAPI-46 PET/CT imaging, specifically early volume-based PET parameters, was associated with patients with recent disease progression of SSc-ILD. Prospective validation in treatment-response studies is needed to confirm the clinical utility of these PET parameters and their identified preliminary thresholds.
Advertisement
- Title
- Exploratory evaluation of early 68Ga-FAPI-46 PET/CT volume-based parameters in systemic sclerosis-associated interstitial lung disease
- Authors
-
Sarah Beishan Tai
Wei Ming Chua
Cherie Wei Qi Ng
Maria Noviani
Wei Ping Tham
Seyed Ehsan Saffari
Winnie Wing Chuen Lam
David Chee Eng Ng
Adrian Shoen Choon Seng Low
Wanying Xie
Andrea Hsiu Ling Low
- Publication date
- 02-02-2026
- Publisher
- Springer Berlin Heidelberg
- Published in
-
European Journal of Nuclear Medicine and Molecular Imaging
Print ISSN: 1619-7070
Electronic ISSN: 1619-7089 - DOI
- https://doi.org/10.1007/s00259-025-07710-4
This content is only visible if you are logged in and have the appropriate permissions.
This content is only visible if you are logged in and have the appropriate permissions.